Sino-Singapore longitude and latitude client June 14, after the news of Hainan has successfully developed an injection for the prevention of African swine fever virus, Hainan Agricultural and Rural Department responded on the 13th that it is only at the stage of research and development of drugs for the prevention and treatment of African swine fever virus infection. It is too early to talk about the success of research and development or production and use. Meanwhile, Haiyin Co., Ltd., whose main business is Internet Finance and Commercial Real Estate, said Wednesday that it and Professor Xu Qitai, an expert in betel nut research in Hainan, had successfully developed and patented the Pearl Polysaccharide Injection for the prevention of African swine fever. Is this a coincidence?
As the incident continued to ferment, on the evening of the 13th, Pearl polysaccharide can prevent African swine fever, the head of the Ministry of Agriculture and Rural Affairs said that the development of research on prevention and control of African swine fever must be in accordance with the law to ensure biosafety. In addition, up to now, no preventive and therapeutic drugs or vaccines against African swine fever virus have been accepted. The so-called Pearl Polysaccharide Injection for the Prevention and Treatment of African Swine Fever has not applied for veterinary drug registration, and the enterprises concerned have not obtained the Veterinary Drug Production License.
DATA FIGURE: Live pig farm. China News Agency reporter Lin Hao-zhao
Earlier, it was reported that the Hainan Agricultural and Rural Department had found Xu Qitai himself to prepare for the production of Jinzhu Polysaccharide Injection. However, Haiyin announced that Xu Qitai and his team had successfully developed vaccines which was quite suspicious of rubbing hot spots.
On the morning of the 13th, Sino-Singapore Jingwei Client called the Department of the Education Center of Hainan Agricultural and Rural Department. The staff of the other side said, Without the enterprise you mentioned, we only have a research team of Southern Medicine to do this thing (research and development of African swine fever vaccine). He also said that there are a lot of malicious speculation, he has not heard of the enterprise.
On that day, Haiyin received a letter of inquiry from Shenzhen Stock Exchange asking the company to analyze whether the Pearl polysaccharide injection conforms to the medical definition of the vaccine and whether it belongs to the African swine fever vaccine. The latter is required to disclose the specific sources of the effective data in the previous announcement that Pearl polysaccharide injection can achieve effective prevention of African swine fever at least 92%, and whether there are official certificates or other supporting documents.
In addition, the Shenzhen Stock Exchange requires Haiyin to verify and disclose the patent type, patent number, patentee, acquisition method, application time, protection period and specific approval information of Jinzhu Polysaccharide Injection and provide relevant certification documents.
Sino-Singapore Jingwei Client immediately dialed the Haiyin Stock Investor Hotline for inquiry, the other side said: everything is subject to the content of the announcement. As for the inquiry letter issued by Shenzhen Stock Exchange, it said that the company would reply within the prescribed time.
In the secondary market, Haiyin shares opened high on the 13th, closing at 3.34 yuan per share, up 6.03%, with the latest market value of 7.283 billion yuan.
The Ministry of Agriculture and Rural Areas Sounds Late at Night
Sea Seal Stock Trapped Vaccine Rashomon
On the evening of June 11, Guangdong Haiyin Group Co., Ltd. announced that the company intends to sign a cooperation contract with Xu Qitai and Hainan Jinzhu Agricultural Development Co., Ltd. Based on Professor Xu Qitai and his research teams research achievements on the prevention of African swine fever and related patented technology, the company intends to cooperate with the research team to invest in the field of natural drugs to support the prevention and treatment of African swine fever.
Xu Qitai and his team successfully developed the Pearl Polysaccharide Injection and had patent rights (including patent application rights) to achieve an effective prevention of African swine fever of no less than 92%. In addition, after the signing of the contract, Haiyin shares intend to provide Professor Xu Qitai and his research team with RMB 100 million as a performance bond to prepare for the launch of the African swine fever vaccine.
Haiyin shares and Hainan South Pharmaceutical Team developed the African classical swine fever vaccine drug ingredients are pearl polysaccharide, but the efficacy of the drug ingredients on the Internet is very few.
According to the first financial report, pearl polysaccharide may be related to betel nut extract, but it has not been approved by the Ministry of Agriculture and Rural Areas, so it can not be produced at present. There are also reports that Haiyin shares currently do not have the relevant patents of Jinzhu Polysaccharide Injection.
The Ministry of Agriculture and Rural Affairs pointed out that up to now, no drugs or vaccines for the prevention and treatment of African swine fever virus have been accepted. The so-called Pearl Polysaccharide Injection for the Prevention and Treatment of African swine fever has not applied for veterinary drug registration, and the enterprises concerned have not obtained the Veterinary Drug Production License.
At the same time, the Ministry of Agriculture and Rural Areas said that the Hainan Pharmaceutical Research Team and related enterprises have so far failed to file applications for clinical trials of new veterinary drugs with the Hainan Agricultural and Rural Department. In the absence of animal experimental data on African swine fever virus, the report that Pearl polysaccharide can effectively control African swine fever lacks scientific basis.
One of the major concerns of the vaccine incident is Xu Qitais identity and background. He was also named Xu Qitai, who served as president of the Pharmaceutical College of Henan University and doctoral supervisor before serving as chairman of Green Betelnut Company.
Hainan Green Betelnut Science and Technology Development Co., Ltd. is an innovative and technological enterprise founded by Xu Qitai under the guidance of Professor Hou Yunde, academician of the two academies, which integrates the research of Southern medicine germplasm resources, plant extraction, product development and industrialization. The core product is areca nut extract arecol.
It has been reported that most of the patents under Xu Qitais name are related to betel nut, including betel phenol cigarettes, non-toxic chewing betel nut, betel nut dried beans, betel nut gum, betel nut charcoal coffee, betel nut cola and other commodities.
Xu Qitai and his team set up Jinzhu Company to realize the patent industrialization of Jinzhu Polysaccharide Injection. The State Enterprise Credit Information Publication System shows that the legal representative of Jinzhu Company is licensed. The company was established on May 24, 2019, and its registered address is the room of a hotel in Haikou City.
Coincidentally, a red-headed document issued by Hainan Provincial Agricultural and Rural Department circulated on the Internet showed that Xu Qitai and his team had been found by Hainan Provincial Agricultural Department to develop an African swine fever vaccine. The document was entitled Letter from Hainan Provincial Agricultural and Rural Department on Businessmen Requesting to Prepare for the Production of Pearl Polysaccharide Injection, and the date of payment was May 27, 2019.
Red Head Documents Spreading on the Internet
In order to verify whether the Hainan Agricultural and Rural Department has contacted Xu Qitai and his team and whether the official is clear about Haiyins investment in the development of African swine fever vaccine, the client of Sino-Singapore Jingwei called the Department of Education Center of Hainan Agricultural and Rural Department on the morning of the 13th, and the staff of the other side said, There is no such enterprise as you said, we only have it. A team of Southern Pharmaceutical researchers is doing this (developing an African swine fever vaccine). The purpose of the announcement issued by Hainan Agricultural Department is to respond to social concerns and guide public opinion correctly. Now there are many malicious hype, I have never heard of this enterprise, and I do not know what it does in the end.
Hainan Agricultural and Rural Department: Its too early to talk about successful development
On June 12, the South China Sea Network published a report entitled Hainan Successfully Developed Injections to Prevent African Swine Fever Virus. At 3 p.m. on June 12, the Hainan Agricultural and Rural Department announced that the Hainan Pharmaceutical Research Team had screened a variety of tropical plants and isolated the compound ingredients to prevent African swine fever virus infection from them, which were made into injections for the prevention of African swine fever. Viral infection, through clinical trials, has shown a certain preventive effect. At the same time, the original announcement signed Hainan Provincial Agricultural and Rural Department is attached.
However, on the evening of December 12, the Hainan Provincial Agricultural and Rural Department denied the news to the media, saying that all the information issued by the official shall prevail.
On June 13, the Hainan Provincial Agricultural and Rural Department issued a Clarification Announcement on its official website. With the support of the Provincial Agricultural and Rural Department, the Hainan Pharmaceutical Research Team screened a variety of tropical plants and isolated the compound ingredients for the prevention of African swine fever virus infection. The formulation was made into the Pearl polysaccharide injection for the prevention of African swine fever virus infection. Preliminary clinical trials have shown a certain preventive effect. Thereafter, more samples, the infection degree in different areas, the possible influence of virus mutation on prevention, the duration of prevention and maintenance, drug safety, stability, cost-effectiveness, raw material resources and the feasibility of industrialization will be further studied and demonstrated.
Announcement on the official website of Hainan Agricultural and Rural Department
According to Hainan Agricultural Department, it is only at the stage of research and development of anti-CSFV drugs. It is too early to talk about the success of research and development or production and use.
African swine fever (CSF) is an acute and severe infectious disease of pigs with a lethal rate of up to 100%. Because of many ways of transmission, prevention and control are not easy. Once the epidemic occurs, it will be difficult to eradicate in a short time. So far, no vaccine has been developed. The official website of the Ministry of agriculture and rural areas showed that on April 19th and 21 this year, there were a number of counties in Danzhou, Wanning and Haikou of Hainan province.
The Ministry of Agriculture and Rural Affairs has given an authoritative statement on the development of African swine fever vaccine by non-governmental organizations: any unit that develops the technology and product development of prevention and control of African swine fever must abide by the relevant regulations such as Regulations on Biosafety Management of Pathogenic Microorganism Laboratories and Regulations on Veterinary Drug Management to ensure biosafety.
The Ministry of Agriculture and Rural Affairs, together with the relevant provincial agricultural and rural departments, will resolutely investigate and deal with the so-called scientific research work that ignores biological safety, violates laws and regulations, or interferes with the overall situation of the prevention and control of swine fever in Africa by lacking scientific basis and exaggerating propaganda and hype. The Ministry of Agriculture and Rural Affairs said.
The player behind the tray is an invisible rich man in Guangzhou.
Guangdong Haiyin Group Co., Ltd. was founded in 1991 and listed on the Shenzhen Stock Exchange in 2008. It is one of the few privately held Commercial Listed Companies in Guangzhou. It is also one of the top 500 private enterprises in China, one hundred private enterprises in Guangdong and Guangzhou. The companys main business includes business operations, financial services and new energy and other fields.
At present, the main business model of Haiyin shares is to rent property in pieces, transform it into a professional market, and then recruit rent from outside, which is also called second landlord. But in fact, in the past ten years, Haiyin shares have frequently crossed borders and adjusted its main business many times, from kaolin and carbon black products sales to commercial property, entertainment industry and financial industry. Since then, Haiyin shares have also established consumer finance companies to develop Internet financial business in 2014-2016, when Internet finance is prevalent.
Some people questioned why Haiyin shares did not make good use of commercial real estate, focusing on the cake of African swine fever vaccine. Affected by African swine fever last year, the performance of domestic animal husbandry listed companies was not ideal. Even Wens shares, Muyuan shares and Zhengbang Science and Technology did not buy Jinzhu Polysaccharide Injection. Why was it included in Haiyin shares? All kinds of doubts need to be solved.
The chairman of Haiyin is Shao Jianming, known as the invisible rich in Guangzhou. In addition, Shao Jianming is also a representative of the 12th National Peoples Congress of Guangdong Province, a member of the Standing Committee of the 15th National Peoples Congress of Guangzhou, a vice-chairman of the 16th Political Consultative Conference of Yuexiu District of Guangzhou, and a vice-chairman of the Guangzhou Federation of Industry and Commerce.
Shao Jianming Source: Official Website of Haiyin Shares
In 2015, media quoted people familiar with the situation as saying that Shao Jianming had invested hundreds of millions of yuan to buy 20 yearsfranchise of Chongqing McDonalds, with 100% of the company. China-Singapore longitude-latitude inquiry found that there are 133 companies under Shao Jianmings name. They are legal representatives of 106 companies and act as shareholders of 11 companies. There are 77 risks and 694 periphery risks in Haiyin Stock, which is chaired by him.
Sino-Singapore Jingwei Client noted that in the past three years, the number of shareholder households of Haiyin shares has been decreasing year by year. As of March 31, 2019, the total number of shareholder households of Haiyin shares was 89,000.
The annual report of Haiyin shares in 2018 shows that the companys annual operating income is 2.507 billion yuan, down 2.12% from the same period last year; the net profit of shareholders belonging to listed companies is 138 million yuan, down 40.13% from the same period last year. By the end of the reporting period, Haiyins total assets were 11.506 billion yuan, down 3.77% from the same period last year.
Haiyin shares explained that the main reasons for the decline in net profit were the increase in financing costs and financial fees; the decrease in gross interest rate of the companys financial services business; the reduction of one-time brand service fees charged by subsidiaries due to renewal of contracts with merchants this year; and the provision for impairment of assets in the long-term equity investment of the companys remaining equity in the entertainment sector during the reporting period.
The performance of Haiyin shares at the beginning of this year is still unsatisfactory. According to its first quarterly report of 2019, the companys business income in the first quarter was 516 million yuan, down 16.9% from the same period of last year; net returns to the mother were 0.23 billion yuan, down 36.3% from the same period of last year; net profits to the non-mother were 0.12 billion yuan, down 65.2%.
Source of this article: responsible editor of Sino-Singapore longitude and latitude: Li Wan_B11284